Ardelyx (ARDX) Gross Profit (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -21.60% |
| Dec 31, 2025 | 19,750.52% |
| Sep 30, 2025 | -100.68% |
| Jun 30, 2025 | 37.93% |
| Mar 31, 2025 | -36.84% |
| Dec 31, 2024 | 18.61% |
| Sep 30, 2024 | 29.36% |
| Jun 30, 2024 | 64.00% |
| Mar 31, 2024 | 32.81% |
| Dec 31, 2023 | -39.86% |
| Sep 30, 2023 | 158.43% |
| Jun 30, 2023 | 91.66% |
| Mar 31, 2023 | -76.03% |
| Dec 31, 2022 | 864.17% |
| Sep 30, 2022 | 78.14% |
| Jun 30, 2022 | 523.50% |
| Mar 31, 2022 | -62.78% |
| Dec 31, 2021 | -12.28% |
| Sep 30, 2021 | -10.66% |
| Jun 30, 2021 | -76.48% |
| Mar 31, 2021 | 209.25% |
| Dec 31, 2020 | -33.47% |
| Sep 30, 2020 | 60.06% |
| Jun 30, 2020 | 39.74% |
| Mar 31, 2020 | -46.09% |
| Dec 31, 2019 | -6.76% |
| Sep 30, 2019 | 13,305.56% |
| Jun 30, 2019 | 101.80% |
| Mar 31, 2019 | -1,276.47% |
| Dec 31, 2018 | -50.00% |
| Sep 30, 2018 | 466.67% |
| Jun 30, 2018 | -98.38% |